870 filings
8-K
LSTA
Lisata Therapeutics Inc
14 Dec 20
Regulation FD Disclosure
8:04am
8-K
LSTA
Lisata Therapeutics Inc
17 Nov 20
Caladrius Biosciences Announces the Resignation of Dr. Douglas Losordo, Chief Medical Officer
4:06pm
10-Q
2020 Q3
LSTA
Lisata Therapeutics Inc
Quarterly report
5 Nov 20
4:15pm
8-K
LSTA
Lisata Therapeutics Inc
5 Nov 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results
4:09pm
4
Whitaker Anne Clem
3 Nov 20
CALADRIUS BIOSCIENCES / Anne Clem Whitaker ownership change
7:02pm
3
uf8z46w
3 Nov 20
CALADRIUS BIOSCIENCES / Anne Clem Whitaker ownership change
7:01pm
4
3u59ekuydvlnaj9t mg
10 Sep 20
CALADRIUS BIOSCIENCES / Michael H. Davidson ownership change
4:01pm
424B3
eqo7nyif5kyj0xw
2 Sep 20
Prospectus supplement
4:03pm
EFFECT
7xmyqw
28 Aug 20
Notice of effectiveness
12:15am
UPLOAD
1iuoui a8iyr
25 Aug 20
Letter from SEC
12:00am
CORRESP
sfmyt5v8ta4vkb61tc
25 Aug 20
Correspondence with SEC
12:00am
S-8
2zys2fscz
18 Aug 20
Registration of securities for employees
4:05pm
8-K
63kwj9yo
13 Aug 20
Caladrius Biosciences Provides Corporate Update and Reports 2020 Second Quarter Financial Results
4:08pm
4
8badyu
12 Aug 20
CALADRIUS BIOSCIENCES / Michael H. Davidson ownership change
9:21am
3
8q6k6 243107q
12 Aug 20
CALADRIUS BIOSCIENCES / Michael H. Davidson ownership change
9:19am
8-K
ekjyb
5 Aug 20
Caladrius Biosciences Announces the Resignation of Joseph Talamo, Chief Financial Officer
4:07pm
8-K
7hdd95b9
28 Jul 20
Caladrius Biosciences Appoints Dr. Michael H. Davidson
8:24am
D
ugvc07qyroptc7b
27 Jul 20
$2M in options / securities to be acquired, sold $2M, 3 investors
9:28am